Cartalax

Cartalax is a synthetic short-chain peptide bioregulator consisting of the amino acid sequence Alanyl-Glutamyl-Aspartic acid (AED). Originally developed at the St. Petersburg Institute of Bioregulation and Gerontology, it is designed to mimic natural protein fragments that maintain cartilage health. Unlike temporary pain relievers, it functions at a cellular level to stimulate the body's internal repair mechanisms within connective tissues. The peptide works by interacting with the genome to "reset" cell function in fibroblasts and chondrocytes. By influencing gene expression, it helps restore the balance between tissue breakdown and synthesis. This makes it a primary focus for research involving osteoarthritis, athletic injury recovery, and age-related joint degeneration, as it targets the underlying structural quality of the joint rather than just masking symptoms.